Northern Trust Corp raised its position in shares of Afya Limited (NASDAQ:AFYA - Free Report) by 109.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 40,054 shares of the company's stock after acquiring an additional 20,957 shares during the period. Northern Trust Corp's holdings in Afya were worth $636,000 at the end of the most recent reporting period.
A number of other large investors also recently modified their holdings of AFYA. Teacher Retirement System of Texas acquired a new position in shares of Afya in the 4th quarter valued at approximately $329,000. Renaissance Technologies LLC boosted its holdings in shares of Afya by 14.0% in the fourth quarter. Renaissance Technologies LLC now owns 412,000 shares of the company's stock valued at $6,543,000 after acquiring an additional 50,700 shares in the last quarter. Wellington Management Group LLP acquired a new stake in Afya in the 4th quarter valued at about $829,000. Doma Perpetual Capital Management LLC boosted its position in shares of Afya by 92.3% in the 4th quarter. Doma Perpetual Capital Management LLC now owns 567,109 shares of the company's stock valued at $9,006,000 after purchasing an additional 272,200 shares during the period. Finally, Van ECK Associates Corp grew its position in Afya by 41.9% during the 4th quarter. Van ECK Associates Corp now owns 9,677 shares of the company's stock worth $154,000 after purchasing an additional 2,856 shares in the last quarter. 88.02% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Separately, Morgan Stanley lowered shares of Afya from an "equal weight" rating to an "underweight" rating and reduced their price target for the stock from $19.00 to $17.00 in a research report on Tuesday, March 11th. Three analysts have rated the stock with a sell rating and two have given a hold rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Reduce" and a consensus target price of $17.60.
Get Our Latest Report on Afya
Afya Stock Down 0.3%
NASDAQ AFYA traded down $0.05 on Wednesday, reaching $17.98. The stock had a trading volume of 14,442 shares, compared to its average volume of 125,044. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 0.51. Afya Limited has a 1 year low of $14.52 and a 1 year high of $19.90. The business has a 50 day moving average price of $18.41 and a 200 day moving average price of $17.10. The company has a market capitalization of $1.69 billion, a price-to-earnings ratio of 14.50, a P/E/G ratio of 0.29 and a beta of 0.60.
Afya Dividend Announcement
The firm also recently announced a -- dividend, which was paid on Friday, April 4th. Shareholders of record on Wednesday, March 26th were paid a $0.232 dividend. The ex-dividend date was Wednesday, March 26th. Afya's dividend payout ratio (DPR) is presently 17.42%.
Afya Company Profile
(
Free Report)
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.
Further Reading

Before you consider Afya, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Afya wasn't on the list.
While Afya currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.